The BC Bud Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05553A1075
CAD
0.03
0 (-16.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The BC Bud Corp. stock-summary
stock-summary
The BC Bud Corp.
Pharmaceuticals & Biotechnology
Entheos Capital Corp. is a Canada-based company. The Company offers a range of financial and communications services to companies in various industry sectors. The Company provides business advisory services in connection with venture capital markets, investor relations, initial public offerings and secondary financings, mergers and acquisitions, public market administration, as well as media and marketing advice. The Company offer Business Advisory and Capital Markets services to a range of growth companies. The Company's Business Advisory platform offers a range of products and services designed for clients' exposure and visibility within a network of Investment Advisors in independent and bank-owned investment dealers.
Company Coordinates stock-summary
Company Details
Suite 2080-777 Hornby Street , VANCOUVER BC : V6Z 1S4
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Douglas Mason
Chief Executive Officer, Director
Sead Hamzagic
Chief Financial Officer, Secretary, Independent Director
Mr. Joseph Bleackley
Director
Mr. Corey Larricq
Director
Mr. Brayden Sutton
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - May 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 7 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.96

stock-summary
Return on Equity

-110.36%

stock-summary
Price to Book

4.85